Feds Take Hard Look at Medtronic Bone-Growth Products

by Sokolove Law

Medtronic’s bone-growth products are coming under increasing scrutiny by the federal government.

The New York Times reports that the Food and Drug Administration (FDA) recently rejected the company’s request to sell a new spinal infusion device called Amplify, a stronger version of its already approved Infuse Bone Growth product. Now, it appears that a Department of Justice investigation into the marketing of Infuse is broadening. However, the company has not been charged to date with any wrongdoing in the long-running investigation.

The FDA issued a warning in 2008 regarding the use of bone-growth proteins in an off-label fusion procedure used to treat neck pain, citing reports of life-threatening injuries.

If you or a loved one has suffered an injury due to a medical device, you may want to contact an attorney to learn about your legal rights and see what types of legal action you may be able to pursue.

Learn more

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>